Literature DB >> 19615419

Functional roles of the tegument proteins of herpes simplex virus type 1.

Barbara J Kelly1, Cornel Fraefel, Anthony L Cunningham, Russell J Diefenbach.   

Abstract

Herpes virions consist of four morphologically distinct structures, a DNA core, capsid, tegument, and envelope. Tegument occupies the space between the nucleocapsid (capsid containing DNA core) and the envelope. A combination of genetic, biochemical and proteomic analysis of alphaherpes virions suggest the tegument contains in the order of 20 viral proteins. Historically the tegument has been described as amorphous but increasing evidence suggests there is an ordered addition of tegument during assembly. This review highlights the diverse roles, in addition to structural, that tegument plays during herpes viral replication using as an example herpes simplex virus type 1. Such diverse roles include: capsid transport during entry and egress; targeting of the capsid to the nucleus; regulation of transcription, translation and apoptosis; DNA replication; immune modulation; cytoskeletal assembly; nuclear egress of capsid; and viral assembly and final egress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19615419     DOI: 10.1016/j.virusres.2009.07.007

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  63 in total

Review 1.  Microvesicles and viral infection.

Authors:  David G Meckes; Nancy Raab-Traub
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

2.  Immune Escape via a Transient Gene Expression Program Enables Productive Replication of a Latent Pathogen.

Authors:  Jessica A Linderman; Mariko Kobayashi; Vinayak Rayannavar; John J Fak; Robert B Darnell; Moses V Chao; Angus C Wilson; Ian Mohr
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

3.  Elucidation of the block to herpes simplex virus egress in the absence of tegument protein UL16 reveals a novel interaction with VP22.

Authors:  Jason L Starkey; Jun Han; Pooja Chadha; Jacob A Marsh; John W Wills
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

4.  Analysis of the interaction between the essential herpes simplex virus 1 tegument proteins VP16 and VP1/2.

Authors:  Stanislava Svobodova; Susanne Bell; Colin M Crump
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

5.  Herpes simplex virus tegument ICP0 is capsid associated, and its E3 ubiquitin ligase domain is important for incorporation into virions.

Authors:  Mark G Delboy; Carlos R Siekavizza-Robles; Anthony V Nicola
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

6.  Direct and specific binding of the UL16 tegument protein of herpes simplex virus to the cytoplasmic tail of glycoprotein E.

Authors:  Pei-Chun Yeh; Jun Han; Pooja Chadha; David G Meckes; Michael D Ward; O John Semmes; John W Wills
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

7.  Immediate-early protein ME53 forms foci and colocalizes with GP64 and the major capsid protein VP39 at the cell membranes of Autographa californica multiple nucleopolyhedrovirus-infected cells.

Authors:  Jondavid de Jong; David A Theilmann; Basil M Arif; Peter J Krell
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

8.  Identification of interaction domains within the UL37 tegument protein of herpes simplex virus type 1.

Authors:  Michelle A Bucks; Michael A Murphy; Kevin J O'Regan; Richard J Courtney
Journal:  Virology       Date:  2011-05-20       Impact factor: 3.616

9.  Fine structure of the vaccinia virion determined by controlled degradation and immunolocalization.

Authors:  Nissin Moussatche; Richard C Condit
Journal:  Virology       Date:  2014-12-08       Impact factor: 3.616

10.  ORF11 protein interacts with the ORF9 essential tegument protein in varicella-zoster virus infection.

Authors:  Xibing Che; Stefan L Oliver; Mike Reichelt; Marvin H Sommer; Jürgen Haas; Tihana L Roviš; Ann M Arvin
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.